Back to Search
COLIN BUTTERFIELD, M.D.
M.D.
Internal Medicine Physician
NPI: 1952417578IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
036070282(IL)036.070282(IL)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE
Class of 1982
Research & Publications (12)
New auxin analogs with growth-promoting effects in intact plants reveal a chemical strategy to improve hormone delivery.
PMID 18818305·Proc Natl Acad Sci U S A·2008
8-other
PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.
PMID 18199835·Proc Natl Acad Sci U S A·2008
7-preclinical
PPARalpha deficiency in inflammatory cells suppresses tumor growth.
PMID 17327920·PLoS One·2007
7-preclinical
Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro.
PMID 17023588·Blood·2007
7-preclinical
Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage.
PMID 16418262·Proc Natl Acad Sci U S A·2006
7-preclinical
Dose-dependent response of FGF-2 for lymphangiogenesis.
PMID 15289610·Proc Natl Acad Sci U S A·2004
7-preclinical
Inhibition of angiogenesis by THAM-derived cotelomers endowed with thalidomide moieties.
PMID 14698173·Bioorg Med Chem Lett·2004
4-observational
Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): loop 6 is a novel angiogenesis inhibitor.
PMID 12900406·J Biol Chem·2003
7-preclinical
Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis.
PMID 12682294·Proc Natl Acad Sci U S A·2003
7-preclinical
PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis.
PMID 12370270·J Clin Invest·2002
7-preclinical
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.
PMID 10766175·Cancer Res·2000
7-preclinical
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model.
PMID 10760260·Proc Natl Acad Sci U S A·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2 SAINT ANTHONYS WAY, SUITE 205
ALTON, IL 62002 - Phone
- (618) 462-2222
Quick Facts
- NPI
- 1952417578
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 44
- Publications
- 12
Are you this provider?
Claim Your Profile